NCT00038636已完成3 期
A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Abbott
- 入组人数
- 36
- 试验地点
- 14
- 主要终点
- Virologic and immunologic activity evaluations include plasma HIV RNA, CD4 and CD8 cell counts
研究概览
简要总结
The purpose of this study is to determine the safety and effectiveness of a high dose of ABT-378/ritonavir
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Virologic and immunologic activity evaluations include plasma HIV RNA, CD4 and CD8 cell counts
次要结局
未报告次要终点
研究者
研究点 (14)
Loading locations...
相似试验
已完成
1 期
A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease InhibitorsHIV InfectionsNCT00004580Abbott
终止
2 期
A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's DiseaseAlzheimer's DiseaseNCT00069849Abbott64
已完成
3 期
A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque PsoriasisPlaque PsoriasisNCT00570986AbbVie (prior sponsor, Abbott)1,465
已完成
2 期
ABT-378/Ritonavir and Efavirenz in HIV-Infected Patients Who Have Taken More Than One Protease Inhibitor in the PastHIV InfectionsNCT00004582ViRx
已完成
1 期
A Multiple Dose Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-288 in Stable Subjects With SchizophreniaSchizophreniaNCT00888693AbbVie81